Lagevrio Archives -

Merck & Co has reported record sales of its cancer immunotherapy Keytruda in the second quarter, as members

Merck sees big lift in Keytruda sales, as Senate probes its taxes

https://pharmaphorum.com/news/merck-sees-big-lift-in-keytruda-sales-as-senate-probes-its-taxes/

Orders for Merck & Co’s oral antiviral for COVID-19 helped to swell the drugmaker’s first quarter revenues by

Merck makes $3.2bn from COVID-19 drug Lagevrio in Q1

https://pharmaphorum.com/news/merck-makes-3-2bn-from-covid-19-drug-lagevrio-in-q1/

Already making big profits from its COVID-19 vaccine, Pfizer looks set to bolt on another big revenue stream

Pfizer gets bumper $5.3bn order from US for oral COVID drug

https://pharmaphorum.com/news/pfizer-gets-bumper-5-3bn-order-from-us-for-oral-covid-drug/

An oral antiviral drug developed by Pfizer has been shown to dramatically cut the risk of hospitalisation or

Pfizer’s pill cuts COVID deaths and hospitalisations by 90%

https://pharmaphorum.com/news/pfizers-pill-cuts-covid-deaths-and-hospitalisations-by-90/

Merck & Co and Ridgeback’s oral antiviral molnupiravir has been approved in its first market – the UK

UK first to authorise Merck/Ridgeback’s COVID pill molnupiravir

https://pharmaphorum.com/news/uk-first-to-authorise-merck-ridgebacks-covid-pill-molnupiravir/

Lagevrio